Neuralink has made monumental strides in 2024 and 2025, including successful human trials and ground-breaking applications like mind-controlled devices and vision restoration for the blind. Discover ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.